Phase 1 Adult Solid Tumor Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours

Lung CancerAdvanced Solid TumorNon-small Cell Lung Cancer+4 more

DeuterOncology55 enrolled13 locationsNCT05752552

Recruiting

Phase 1

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors

Advanced Solid TumorCancerNSCLC+5 more

TOLREMO therapeutics AG50 enrolled7 locationsNCT06403436

Recruiting

Phase 1Phase 2

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Unspecified Adult Solid Tumor, Protocol Specific

Maastricht University Medical Center126 enrolled5 locationsNCT04954599